Literature DB >> 8842559

Reduced platelet glutathione peroxidase activity and serum selenium concentration in atopic asthmatic patients.

N L Misso1, K A Powers, R L Gillon, G A Stewart, P J Thompson.   

Abstract

BACKGROUND: Asthmatic inflammation results in increased oxygen free radical generation and assessment of the activity of the selenium (Se) dependent anti-oxidant enzyme, glutathione peroxidase (GSH-Px) in asthma may therefore be important.
OBJECTIVE: To test the hypothesis that reduced GSH-Px activity and Se intake contribute to asthmatic inflammation, platelet and whole blood GSH-Px activities and serum and whole blood Se concentrations were measured and compared in atopic and non-atopic asthmatic patients and non-asthmatic control subjects.
METHODS: GSH-Px activities of whole blood and isolated platelets were assessed in 41 asthmatic patients (33 atopic) and 41 age- and sex-matched non-asthmatic subjects (15 atopic) by spectrophotometric assay based on the oxidation of NADPH. Se concentrations were determined by semi-automated fluorimetric assay.
RESULTS: Mean (+/-SD) platelet GSH-Px activity was lower in asthmatic (89.5 +/- 45.7 mumol NADPH oxidized min-1 g-1 of protein) than in non-asthmatic subjects (109.9 +/- 41.9; P = 0.038) and in atopic (89.7 +/- 45.1, n = 48) compared with non-atopic subjects (113.7 +/- 40.9, n = 34; P = 0.016). Mean whole blood GSH-Px activity was also lower in atopic (12.2 +/- 5.2 mumol NADPH oxidized min-1 g-1 of Hb) than in non-atopic subjects (14.5 +/- 4.2; P = 0.038). In non-asthmatic subjects, the mean whole blood GSH-Px activity was lower in men (9.9 +/- 3.5) than in women (14.5 +/- 3.7; P = 0.0004) and was positively correlated with age (r = 0.51; P = 0.0006). Mean serum Se was lower in asthmatic (1.07 +/- 0.12 mumol/L) than in non-asthmatic subjects (1.16 +/- 0.31; P = 0.036). Using multiple linear regression, asthma was an independent predictor of decreased platelet GSH-Px after gender, age and serum Se were taken into account (P = 0.048) while atopy was a significant predictor of low whole blood GSH-Px independent of asthma, gender, age and whole blood Se (P = 0.033).
CONCLUSIONS: In addition to Se status, atopy, gender and age all appear to influence GSH-Px activity, although the relative importance of these factors may differ in asthmatic and non-asthmatic populations. It seems likely that the reduced activity of this enzyme in platelets and blood may reflect mechanisms associated with the pathogenesis and severity of asthma.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8842559

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  12 in total

Review 1.  Oxidant stress in asthma.

Authors:  R Dworski
Journal:  Thorax       Date:  2000-10       Impact factor: 9.139

Review 2.  Glutathione redox control of asthma: from molecular mechanisms to therapeutic opportunities.

Authors:  Anne M Fitzpatrick; Dean P Jones; Lou Ann S Brown
Journal:  Antioxid Redox Signal       Date:  2012-03-09       Impact factor: 8.401

Review 3.  The role of selenium in inflammation and immunity: from molecular mechanisms to therapeutic opportunities.

Authors:  Zhi Huang; Aaron H Rose; Peter R Hoffmann
Journal:  Antioxid Redox Signal       Date:  2012-01-09       Impact factor: 8.401

Review 4.  Selenium, selenoproteins and the thyroid gland: interactions in health and disease.

Authors:  Lutz Schomburg
Journal:  Nat Rev Endocrinol       Date:  2011-10-18       Impact factor: 43.330

5.  Dietary supplements and asthma: another one bites the dust.

Authors:  Johanna Feary; John Britton
Journal:  Thorax       Date:  2007-06       Impact factor: 9.139

6.  Freeze-dried targeted mannosylated selenium-loaded nanoliposomes: development and evaluation.

Authors:  Susanne R Youngren; Rohit Mulik; Byoung Jun; Peter R Hoffmann; Kenneth R Morris; Mahavir B Chougule
Journal:  AAPS PharmSciTech       Date:  2013-09       Impact factor: 3.246

Review 7.  Selenium and asthma.

Authors:  Robert L Norton; Peter R Hoffmann
Journal:  Mol Aspects Med       Date:  2011-10-15

8.  Randomised, double blind, placebo-controlled trial of selenium supplementation in adult asthma.

Authors:  Seif O Shaheen; Roger B Newson; Margaret P Rayman; Angela P-L Wong; Michael K Tumilty; Joanna M Phillips; James F Potts; Frank J Kelly; Patrick T White; Peter G J Burney
Journal:  Thorax       Date:  2007-01-18       Impact factor: 9.139

9.  Monitoring antioxidant enzymes in red cells during allergen immunotherapy.

Authors:  N Lukan; O Racz; I Mocnejova; I Tkac
Journal:  J Physiol Biochem       Date:  2008-06       Impact factor: 4.158

Review 10.  Selenium supplementation for asthma.

Authors:  M F Allam; R A Lucane
Journal:  Cochrane Database Syst Rev       Date:  2004
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.